(Q24248065)

title

Naloxone for shock (English)

0 references

1

B. Boeuf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14584016

26 March 2024

Benoit Boeuf

1

B

Boeuf

1 reference

9 December 2023

Véronique Poirier

2

V

Poirier

1 reference

9 December 2023

France Gauvin

3

F

Gauvin

1 reference

9 December 2023

Anne-Marie Guerguerian

4

A M

Guerguerian

1 reference

9 December 2023

Chantal Roy

5

C

Roy

1 reference

9 December 2023

Catherine Farrell

6

C A

Farrell

1 reference

9 December 2023

Jacques Lacroix

7

J

Lacroix

1 reference

9 December 2023

V. Poirier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14584016

26 March 2024

F. Gauvin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14584016

26 March 2024

A. M. Guerguerian

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14584016

26 March 2024

C. Roy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14584016

26 March 2024

C. A. Farrell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14584016

26 March 2024

J. Lacroix

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14584016

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14584016

26 March 2024

publication date

21 July 2003

0 references

2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14584016

full work available at URL

26 March 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036847

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14584016

https://europepmc.org/articles/PMC9036847

26 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14584016

https://europepmc.org/articles/PMC9036847?pdf=render

26 March 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14584016

https://doi.org/10.1002/14651858.cd004443

26 March 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14584016

https://onlinelibrary.wiley.com/doi/full/10.1002/14651858.CD004443

26 March 2024

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004443

Cochrane Database of Systematic Reviews

26 March 2024

published in

0 references

cites work

Naloxone and methylprednisolone sodium succinate enhance sympathomedullary discharge in patients with septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

Effects of prolonged naloxone infusion in septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

Naloxone and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

Activation and inhibition of the endogenous opioid system in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

A method for assessing the quality of a randomized control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

Opiate antagonists: a role in the treatment of hypovolemic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

Beta-endorphin in the immune system--mediator of pain and stress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

PRISM III: an updated Pediatric Risk of Mortality score

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

Effect of naloxone on immune responses after hemorrhagic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

Therapy of shock with naloxone: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

Naloxone treatment of toxic shock syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Naloxone in reversal of hypotension in septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Naloxone in treatment of circulatory shock resistant to conventional therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Naloxone in circulatory shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Early use of naloxone in shock--a clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Continuous naloxone infusion in two neonates with septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Naloxone in irreversible shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD004443

1 reference

7 January 2021

Pressor effect of naloxone in septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Response to naloxone in septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Naloxone and anaphylactic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Plasma beta-endorphin levels in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Clinical biostatistics. LIV. The biostatistics of concordance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Hemodynamic responses to low doses of naloxone after narcotic-nitrous oxide anesthesia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Acute pulmonary edema in healthy teenagers following conservative doses of intravenous naloxone.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Naloxone in septic shock.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Efficacy and safety of naloxone in septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Naloxone therapy of human septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Failure of naloxone in septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Prospective, controlled, randomized trial of naloxone infusion in early hyperdynamic septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Naloxone decreases tolerance to hypotensive, hypovolemic stress healthy humans

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Naloxone in fulminant meningococcemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Effects of Naloxone Infusion in Patients with Septic Shock and Renal Failure: A Limited Experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Peptides opioïdes, substances opiacées et réponse immunitaire

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Reversal of hypotension by continuous naloxone infusion in a ventilator-dependent patient

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004443

7 January 2021

Naloxone versus placebo in treatment of septic shock

1

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004443

Naloxone fails to reverse blood pressure in shock: a double blind study in man

26 March 2024

4

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004443

Effect of naloxone on shock in a patient with fulminant hepatic failure

26 March 2024

39

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004443

Use of naloxone in septic shock

26 March 2024

45

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004443

Naloxone therapy of septic shock

26 March 2024

64

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004443

Naloxone in septic shock: report of two cases

26 March 2024

65

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004443

Naloxone for haemorrhagic fever shock?

26 March 2024

73

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004443

26 March 2024

Identifiers

release_dd7xqvvgonau7dkrfgy56e6tyq

0 references

Fatcat ID

0 references

PMC publication ID

9036847

1 reference

National Center for Biotechnology Information